CC
BMY icon

Centiva Capital’s Bristol-Myers Squibb BMY Stock Holding History

Centiva Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$67.9M Buy
1,120,200
+246,200
+28% +$14.4M 0.5% 39
2025
Q4 		$47.1M Buy
+874,000
New +$42M 0.38% 52
2024
Q2 		– Sell
-20,700
Closed -$1.12M – 2081
2024
Q1 		$1.12M Buy
+20,700
New +$1.05M 0.03% 615
2023
Q4 		– Sell
-10,000
Closed -$580K – 1824
2023
Q3 		$580K Buy
+10,000
New +$613K 0.01% 887
2023
Q2 		– Sell
-24,500
Closed -$1.7M – 1648
2023
Q1 		$1.7M Sell
24,500
-43,000
-64% -$3.03M 0.04% 452
2022
Q4 		$4.86M Sell
67,500
-20,100
-23% -$1.52M 0.14% 161
2022
Q3 		$6.23M Sell
87,600
-22,000
-20% -$1.6M 0.12% 119
2022
Q2 		$8.44M Buy
109,600
+42,100
+62% +$3.21M 0.2% 70
2022
Q1 		$4.93M Buy
67,500
+47,700
+241% +$3.2M 0.09% 178
2021
Q4 		$1.24M Buy
19,800
+17,820
+900% +$1.05M 0.03% 530
2021
Q3 		$117K Sell
1,980
-37,820
-95% -$2.49M 0.01% 1017
2021
Q2 		$2.66M Buy
+39,800
New +$2.6M 0.06% 263
2020
Q1 		– Sell
-35,900
Closed -$2.3M – 638
2019
Q4 		$2.3M Buy
35,900
+12,600
+54% +$722K 0.11% 177
2019
Q3 		$1.18M Hold
23,300
– – 0.07% 205
2019
Q2 		$1.06M Sell
23,300
-26,200
-53% -$1.22M 0.06% 207
2019
Q1 		$2.36M Sell
49,500
-44,300
-47% -$2.21M 0.16% 103
2018
Q4 		$4.88M Buy
93,800
+46,600
+99% +$2.5M 0.39% 42
2018
Q3 		$2.93M Buy
+47,200
New +$2.8M 0.25% 61

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centiva Capital's BMY Position: Q1 2026 in Review

Centiva Capital reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q1 2026, selling an estimated $2.36M and leaving 81,733 shares worth $4.96M. The position accounts for 0.04% of the portfolio, ranked #280.

Centiva Capital first reported a position in BMY in Q3 2018 and has held it in 25 quarters since. The position peaked at $6.59M in Q4 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Centiva Capital held 81,733 shares of Bristol-Myers Squibb worth $4.96M as of Q1 2026.
  • Centiva Capital sold 40,450 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.36M.
  • Bristol-Myers Squibb made up 0.04% of Centiva Capital's portfolio in Q1 2026, its #280 holding.
  • Centiva Capital first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 25 quarters since.
  • Centiva Capital's Bristol-Myers Squibb position peaked at $6.59M in Q4 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.